These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32100041)

  • 1. Evaluation of the efficacy of WhatsApp through a harm reduction intervention group for injecting drug users.
    Calvo F; Turró-Garriga O; Carbonell X
    Adicciones; 2021 Jul; 33(3):201-216. PubMed ID: 32100041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and Testing the
    Calvo F; Carbonell X; Mundet C
    Front Public Health; 2020; 8():493321. PubMed ID: 33330297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction interventions for people who inject drugs.
    Nelson EU
    Lancet Glob Health; 2023 May; 11(5):e632-e633. PubMed ID: 36996859
    [No Abstract]   [Full Text] [Related]  

  • 5. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
    Mburu G; Ayon S; Tsai AC; Ndimbii J; Wang B; Strathdee S; Seeley J
    Harm Reduct J; 2018 May; 15(1):29. PubMed ID: 29801494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.
    Meylakhs P; Aasland A; Grønningsæter A
    Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.
    Fernàndez-López L; Folch C; Majó X; Gasulla L; Casabona J
    AIDS Care; 2016; 28(6):712-6. PubMed ID: 27007000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
    Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
    Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.
    Stengel CM; Mane F; Guise A; Pouye M; Sigrist M; Rhodes T
    Harm Reduct J; 2018 Feb; 15(1):9. PubMed ID: 29486774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland.
    Mihailovic A; Tobin K; Latkin C
    AIDS Behav; 2015 Oct; 19(10):1792-800. PubMed ID: 25845530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of harm reduction education on decreasing risky-behaviour among injecting drug users in Egypt.
    Ghaddar A; Ghaly A
    Sex Transm Infect; 2016 Dec; 92(8):628. PubMed ID: 27864439
    [No Abstract]   [Full Text] [Related]  

  • 18. A preliminary needs assessment of American Indians who inject drugs in northeastern Montana.
    Anastario M; FourStar K; Ricker A; Dick R; Skewes MC; Rink E
    Harm Reduct J; 2017 May; 14(1):22. PubMed ID: 28482846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.